本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Skye Bioscience Inc.

0.7500
-0.0230-2.98%
盤後0.7300-0.0200-2.67%19:50 EDT
成交量:25.07萬
成交額:19.10萬
市值:2,503.41萬
市盈率:-0.53
高:0.7999
開:0.7940
低:0.7401
收:0.7730
52周最高:5.75
52周最低:0.5655
股本:3,337.88萬
流通股本:1,988.22萬
量比:1.49
換手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):-1.4100
每股收益(LYR):-1.4100
淨資產收益率:-126.85%
總資產收益率:-71.93%
市淨率:1.25
市盈率(LYR):-0.53

資料載入中...

2021/07/26

重要事件披露

8-K - Current report
2021/07/22

重要事件披露

8-K - Current report
2021/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/02

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/19

重要事件披露

8-K - Current report
2020/11/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/28

重要事件披露

8-K - Current report
2020/08/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/13

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/12

重要事件披露

8-K - Current report
2020/08/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/05

重要事件披露

8-K - Current report
2020/07/29

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/13

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933